Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by King Steven W, Director. Officer active across 1 company, notably Oncotelic Therapeutics, Inc.. Aggregated, 1 reports have been published. Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Steven W. King is a Director at Oncotelic Therapeutics, Inc. As a board member, he plays a key role in the governance of the company, providing his expertise and strategic advice. Steven is involved in making important decisions that influence the direction of Oncotelic, contributing to its development and growth in the biopharmaceutical sector. His diverse experience enriches discussions within the board.